GLP-1 Vision Loss Lawsuit: Do I Qualify?

Use our eligibility screener to find out if you may have a claim. This takes about 2 minutes and is completely free with no obligation.

Last Updated: March 2026  |  Legal Disclaimer

Step 1 of 5

Were you prescribed any of the following GLP-1 drugs?

Full Eligibility Criteria

To file a claim in MDL 3163 or a related GLP-1 NAION lawsuit, you generally need to meet these requirements:

✅ GLP-1 Drug Prescription

You were prescribed Ozempic, Wegovy, Rybelsus, Mounjaro, Trulicity, or Zepbound for any reason (diabetes, weight loss, or off-label use).

✅ NAION Diagnosis

An ophthalmologist or neuro-ophthalmologist diagnosed you with NAION or sudden optic nerve-related vision loss. An MRI, visual field test, or fundus photographs may have been taken.

✅ Temporal Connection

Your NAION developed during or after your GLP-1 drug use, not before you started the medication.

✅ Within the Statute of Limitations

Your claim must be filed within your state's time limit — usually 2–3 years from the date of diagnosis or when you discovered the connection to the drug. See your state's deadline.

What Documentation Do You Need?

Start gathering these records now — your attorney will need them:

  • Pharmacy records or prescription history showing GLP-1 drug use
  • Ophthalmology records documenting NAION or sudden vision loss
  • Eye imaging reports (fundus photos, OCT scans, visual field tests)
  • Records from primary care or endocrinologist who prescribed the drug
  • Insurance Explanation of Benefits (EOB) records
Don't wait to get records: Medical records can be lost, destroyed, or harder to obtain years later. Begin collecting your documentation now, even before you've decided whether to file.

Ready to Find Out If You Have a Case?

Our team connects you with experienced GLP-1 mass tort attorneys for a free, no-obligation case evaluation.

Get a Free Case Evaluation →
Did Ozempic, Wegovy, or another GLP-1 drug cause your vision loss? You may qualify for compensation. Check Eligibility →